Document is current
Any future updates will be listed below
-
Authors
Gattu, Arijeet K.
Goldman, Anna L.
Guzelce, Ezgi Caliskan
Galbiati, Francesca
Bhasin, Shalender
- License Information
-
More Information
Article History
Accepted: 20 October 2022
First Online: 10 November 2022
Declarations
:
: SB reports receiving research grants from NIA, NICHD-NCMRR, NINR, PCORI, AbbVie, MIB, FPT, and Transition Therapeutics, and consulting fees from Aditum and OPKO.
: Ethical approval was not needed since this is a review article.
: Not applicable as no human subjects were involved in writing this review article.
: No conflict of interest.
